Advances in Immunological Treatment of Cancer

Overviews cancer immunology and immunotherapy. Explores latest research behind cancer's driving mechanism of immune suppression, cutting-edge therapeutic approaches to combating cancer as well as novel approaches to cancer therapy with a special emphasis on the emerging new principles of immune suppression that drive the disease.

Auteur

Rishabha Malviya, PhD, has 12 years of research experience and is currently Associate Professor of Pharmacy in the School of Medical and Allied Sciences, Galgotias University, India. He has authored more than 150 research and review papers and has authored and edited over 40 books and over 30 book chapters. Dr. Malviya has received an Outstanding Reviewer Award from Elsevier and has been included in the Stanford University's World's Top 2% Scientists, 2020 by Elsevier and Stanford University. He is reviewer, editor, and editorial board member of more than 50 national and international journals. He was an invited author for the magazine Atlas of Science as well as a pharma magazine dealing with the B2B industry, Ingredients South Asia.

Arun Kumar Singh, MPharm, is affiliated with the Department of Pharmacy, School of Medical & Allied Sciences, Galgotias University, India. His areas of interest include nanoformulation, blockchain, IoT, machine learning, cancer, artificial intelligence, and big data. He has authored four books and has published several chapters and journal papers. His strength is his research skill, innovative thinking, leadership qualities, decision-making ability, and positive thinking.

Deepika Yadav earned her BPharm from K R Mangalam University, Gurugram, Haryana and MPharm from Galgotias University, Greater Noida, India. She has authored two books with Apple Academic Press / Taylor and Francis Group and Scrivener Publishing/Wiley as well as book chapters with other reputed international publishers. She is also working on two books with other renowned international publishers.